Positron emission tomography (PET) is a nuclear medicine functional imaging technique that produces three-dimensional images of functional processes in the body. PET scanners are typically used to observe the metabolic processes in the body as an aid or alternative to invasive procedures with contrast-enhanced CT or MRI imaging. PET scans are often used to detect and diagnose cancer or cardiovascular disease, assess the stage of disease, and see how well cancer tumors respond to treatment. Significant technological advancements in PET imaging have allowed for improved resolution and sensitivity, enabling improved detection and characterization of tumours, metastases, and other abnormalities. Advantages such as high sensitivity and utility in staging and restaging of cancer can drive the market growth.
Market Dynamics:
Global positron emission tomography (PET) scanners market growth is driven by rising prevalence of chronic diseases such as cancer and cardiac disorders worldwide. Cancer being one of the leading causes of mortality, early accurate diagnosis and staging is crucial. PET imaging provides functional information and helps detect cancer in early stages. Moreover, technological advancements enabling hybrid scanners with improved resolution and shorter scanning times can drive the market growth. However, high equipment costs and scarcity of skilled professionals can hamper the market growth. Limited reimbursements and regulatory hurdles for new systems can also hamper the market growth. Emerging economies with growing healthcare investments can offer growth opportunities.
Key Features of the Study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook